Concepedia

Mutations in HIV‐1 Reverse Transcriptase Potentially Associated with Hypersusceptibility to Nonnucleoside Reverse‐Transcriptase Inhibitors: Effect on Response to Efavirenz‐Based Therapy in an Urban Observational Cohort

Valerio Tozzi, Mauro Zaccarelli, Pasquale Narciso, Maria Paola Trotta, Francesca Ceccherini‐Silberstein, Patrizio De Longis, Giampiero D’Offizi, Federica Forbici, Roberta D’Arrigo, Evangelo Boumis,

The Journal of Infectious Diseases · 2004 · 35 citations · 18 references

DOIFull text

Open access

Abstract

The M41L, M184V, L210W, and T215Y mutations were associated with a better, although transient, virological outcome in patients treated with efavirenz-based regimens.

References

18

Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents

Annals of Internal Medicine · 1998 · 5.2K citations

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study

Bruno Ledergerber, Matthias Egger, Milos Opravil et al. · The Lancet · 1999 · 933 citations

, , +8

Highly Active Antiretroviral Therapy in a Large Urban Clinic: Risk Factors for Virologic Failure and Adverse Drug Reactions

Gregory M. Lucas, Richard E. Chaisson, Richard D. Moore · Annals of Internal Medicine · 1999 · 853 citations

Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomi sed controlled trial

J. Durant, Philippe Clevenbergh, Philippe Halfon et al. · The Lancet · 1999 · 761 citations

, , +11

Mechanism of Inhibition of HIV-1 Reverse Transcriptase by Nonnucleoside Inhibitors

Rebecca Spence, Warren M. Kati, Karen S. Anderson et al. · Science · 1995 · 521 citations · Full text